Mind Medicine Inc (NASDAQ: MNMD) on Tuesday, soared 6.21% from the previous trading day, before settling in for the closing price of $11.75. Within the past 52 weeks, MNMD’s price has moved between $4.70 and $14.43.
Healthcare Sector giant saw their annual sales surged by 12.11% over the last five years. The company achieved an average annual earnings per share of -30.67%. With a float of $72.68 million, this company’s outstanding shares have now reached $76.77 million.
Mind Medicine Inc (MNMD) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 3.80%, while institutional ownership is 54.82%. The most recent insider transaction that took place on Sep 25 ’25, was worth 110,186. In this transaction Chief Legal Officer of this company sold 11,278 shares at a rate of $9.77, taking the stock ownership to the 293,852 shares. Before that another transaction happened on Sep 25 ’25, when Company’s Chief Executive Officer sold 25,797 for $9.77, making the entire transaction worth $252,037. This insider now owns 804,268 shares in total.
Mind Medicine Inc (MNMD) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.41 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.28) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.08% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 3.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.97, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Analysing the last 5-days average volume posted by the [Mind Medicine Inc, MNMD], we can find that recorded value of 1.93 million was better than the volume posted last year of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 35.78%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 75.90%, which indicates a significant increase from 48.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.93 in the past 14 days, which was higher than the 0.66 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.40, while its 200-day Moving Average is $8.48. Now, the first resistance to watch is $13.05. This is followed by the second major resistance level at $13.63. The third major resistance level sits at $14.40. If the price goes on to break the first support level at $11.70, it is likely to go to the next support level at $10.93. Now, if the price goes above the second support level, the third support stands at $10.35.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
Market capitalization of the company is 1.23 billion based on 76,088K outstanding shares. Right now, sales total 0 K and income totals -108,680 K. The company made 0 K in profit during its latest quarter, and -67,270 K in sales during its previous quarter.
